Papers
7
Total Citations
270
H-Index
7
About
Mark Kubik is a leading head and neck surgical oncologist whose research centers on advancing transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC). His work has fundamentally shaped how surgeons approach this minimally invasive technique, particularly in managing the challenging scenario of cervical unknown primary squamous cell carcinoma. Kubik’s landmark 2017 study on TORS for unknown primaries (69 citations) established critical updates on efficacy and margin status, while his investigation of transcervical arterial ligation (63 citations) provided evidence-based guidance for reducing postoperative hemorrhage severity. His assessment of surgical learning curves (50 citations) has been instrumental in defining competency benchmarks for adopting TORS. Kubik has also made significant contributions to understanding margin status across oropharyngeal subsites (29 citations) and pioneered the use of TORS base-of-tongue mucosectomy for HPV-negative carcinoma of unknown primary (37 citations). His recent work on PET/CT’s limitations in predicting AJCC 8th edition pathologic staging (14 citations) challenges conventional staging paradigms for HPV-related OPSCC. With over 270 cumulative citations, Kubik’s research continues to refine surgical techniques, improve patient safety, and advance precision in oropharyngeal cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7